EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Raman spectroscopic characterization of liver steatosis and fibrosis in a 2D and 3D in vitro thyroxine-treated hypothyroid cellular model

S Maurotti, B Scopacasa, F Scionti, R Pujia, M Frosina, A Mirarchi, N Geirola, R Mare, T Montalcini, P Candeloro, L Tirinato, A Pujia

Molecular and Cellular Endocrinology · 2026

DOI: 10.1016/j.mce.2025.112679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2026. Verfasst von S Maurotti und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, Magna Græcia University, Catanzaro, 88100, Italy. Hauptthemen laut MEDLINE: Spectrum Analysis, Raman, Liver Cirrhosis, Fatty Liver, Hypothyroidism. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero dell'Istruzione dell'Università e della Ricerca, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary hypothyroidism has been associated with metabolic dysfunction-associated steatotic liver disease and, potentially, increased liver fibrosis risk. Although T4-analog drug is one of the standard treatments, its molecular effects on the liver are not fully understood. To elucidate drug-induced hepatic metabolic changes, chronic human 2D and 3D hypothyroid models were developed. The effects of T4 were assessed by Raman spectroscopy and complementary biological techniques to observe lipid and fibrotic changes. In vitro chronic hypothyroidism caused lipid droplet (LDs) accumulation in liver cells which was unaffected by T4 therapy. Notably, TSH and T4 influenced TG fatty acid saturation in different ways: T4-exposed cells accumulated monounsaturated fatty acids at the expense of saturated fatty acids. In the case of liver fibrosis, TSH treatment activated hepatic stellate cells as evidenced by increased collagen secretion and decreased LD content, regardless of T4 co-treatment. Data confirmed that TSH induced pro-inflammatory changes leading to higher inflammasome levels in a 3D liver model. These findings indicate the detrimental effects of elevated TSH levels, and it is worth noting that T4 administration does not reverse the excess of hepatic lipid overload but has the ability to alter its lipid composition. Furthermore, T4 administration did not reverse TSH-induced hepatic fibrogenesis in the hypothyroid cell models. Because micro-Raman spectroscopy is currently restricted to 2D/3D in-vitro systems, further validation in intact tissue and in vivo is warranted. In conclusion, our results highlight the importance of further research into the molecular pathways associated with chronic liver injury in patients with chronic hypothyroidism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spectrum Analysis, RamanLiver CirrhosisFatty LiverHypothyroidismThyroxineModels, BiologicalHumansHepatic Stellate CellsLipid DropletsLipid Metabolism

Stichwörter der Autor:innen

HypothyroidismLipid dropletsLiver fibrosisMASLDRaman spectroscopyT4TSH

Substanzen

Thyroxine

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, Magna Græcia University, Catanzaro, 88100, Italy.
  • Department of Medical and Surgical Sciences, Magna Græcia University, Catanzaro, 88100, Italy.
  • Department of Clinical and Experimental Medicine, Magna Græcia University, Catanzaro, 88100, Italy; Research Center for the Prevention and Treatment of Metabolic Diseases (CR METDIS), Magna Græcia University, Catanzaro,…
  • Department of Clinical and Experimental Medicine, Magna Græcia University, Catanzaro, 88100, Italy; Nanotechnology Research Center, Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro,…
  • Department of Medical and Surgical Sciences, Magna Græcia University, Catanzaro, 88100, Italy. Electronic address: tirinato@unicz.it.
  • Department of Medical and Surgical Sciences, Magna Græcia University, Catanzaro, 88100, Italy; Research Center for the Prevention and Treatment of Metabolic Diseases (CR METDIS), Magna Græcia University, Catanzaro, Ital…

Förderung

  • Ministero dell'Istruzione dell'Università e della Ricerca
  • European Commission

Zitieren

APA

Maurotti, S., Scopacasa, B., Scionti, F., Pujia, R., Frosina, M., Mirarchi, A., Geirola, N., Mare, R., Montalcini, T., Candeloro, P., Tirinato, L., & Pujia, A. (2026). Raman spectroscopic characterization of liver steatosis and fibrosis in a 2D and 3D in vitro thyroxine-treated hypothyroid cellular model. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2025.112679

Vancouver

Maurotti S, Scopacasa B, Scionti F, Pujia R, Frosina M, Mirarchi A, et al. Raman spectroscopic characterization of liver steatosis and fibrosis in a 2D and 3D in vitro thyroxine-treated hypothyroid cellular model. Molecular and Cellular Endocrinology. 2026. doi:10.1016/j.mce.2025.112679

BibTeX
@article{Maurotti2026,
  author = {Maurotti, S and Scopacasa, B and Scionti, F and Pujia, R and Frosina, M and Mirarchi, A and Geirola, N and Mare, R and Montalcini, T and Candeloro, P and Tirinato, L and Pujia, A},
  title = {Raman spectroscopic characterization of liver steatosis and fibrosis in a 2D and 3D in vitro thyroxine-treated hypothyroid cellular model},
  journal = {Molecular and Cellular Endocrinology},
  year = {2026},
  doi = {10.1016/j.mce.2025.112679}
}
Kostenlos starten →